Replication errors, DNA damage, and imperfect DNA repair can all produce a single-base change. Its biological distribution depends partly on the cell lineage involved: a germline event can contribute to inherited variation, while a somatic event develops in a particular tissue. This distinction helps researchers separate changes relevant to inheritance from those associated with tissue-specific genetic differences.
An SNV can have different consequences according to where it occurs. Within a protein-coding sequence, it may alter the encoded protein; in a regulatory region, it may influence gene control; elsewhere, it may show little detectable effect. Interpreting a variant therefore requires considering its genomic context rather than treating every one-nucleotide difference as equally consequential.
A reference sequence provides the baseline against which a nucleotide difference is detected and described. This comparison allows sequencing results to be expressed as specific changes rather than broad statements about genetic difference. The reference does not by itself establish biological importance; researchers still consider location and whether the change occurs in coding, regulatory, or other sequence context.
Researchers identify them by sequencing DNA and examining the resulting sequence in relation to a reference sequence. The workflow connects a laboratory DNA measurement with a defined comparison point. Once a difference is identified, its location can be evaluated to determine whether it lies in a protein-coding region, a regulatory region, or another part of the sequence.
Because SNVs mark precise points of genetic difference, they can support studies of inheritance, population diversity, and disease-associated variation. In inheritance research, they help examine differences passed through germline cells; in population studies, they enable fine-grained comparisons among genetic sequences. Their disease relevance depends on the association observed and the genomic context of each variant.
In cancer biology, researchers examine SNVs as part of cancer genomes, including changes that develop somatically in particular tissues. In studies of drug response and precision biology, these variants can be compared with differences among individuals. Such analyses use sequence variation to investigate tumor genetics and biological differences that may help explain why responses vary.